During the past decade, Prisma Health Cancer Institute - Easley conducted 144 clinical trials. In the 10-year time frame, 144 clinical trials started and 102 clinical trials were completed, i.e. on average, 70.8% percent of trials that started reached the finish line to date. In the past 5 years, 44 clinical trials started and 70 clinical trials were completed. i.e. 159.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Prisma Health Cancer Institute - Easley" #1 sponsor was "National Cancer Institute (NCI)" with 84 trials, followed by "SWOG Cancer Research Network" with 46 trials sponsored, "Alliance for Clinical Trials in Oncology" with 43 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 14 trials sponsored and "Wake Forest University Health Sciences" with 14 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Prisma Health Cancer Institute - Easley" #1 collaborator was "National Cancer Institute (NCI)" with 129 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "NCIC Clinical Trials Group" with 4 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Prisma Health Cancer Institute - Easley" are "Breast Cancer" (11 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Lung Cancer" (7 trials) and "Stage IV Lung Cancer AJCC v8" (7 trials). Many other conditions were trialed in "Prisma Health Cancer Institute - Easley" in a lesser frequency.

Most popular intervention types in "Prisma Health Cancer Institute - Easley" are "Drug" (170 trials), "Other" (150 trials), "Biological" (78 trials), "Procedure" (43 trials) and "Radiation" (15 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (72 trials), "Quality-of-Life Assessment" (54 trials), "Questionnaire Administration" (36 trials), "Cisplatin" (23 trials) and "Nivolumab" (20 trials). Other intervention names were less common.

The vast majority of trials in "Prisma Health Cancer Institute - Easley" are 185 trials for "All" genders, 34 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Prisma Health Cancer Institute - Easley". undefined are not yet recruiting, 46 are recruiting, 101 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 62 completed trials in Prisma Health Cancer Institute - Easley, 4 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Prisma Health Cancer Institute - Easley, 6 "Phase 1" clinical trials were conducted, 86 "Phase 2" clinical trials and 122 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 10 trials that are defined as “Not Applicable".